August 2017

Features

The Latest Treatment Approaches For Uveitis

Don’t hesitate to use immunesuppressing medications in severe patients, surgeons say.

How to Get the Most from OCT-A

Although it’s not yet a mature technology, OCT-A is already providing valuable information about retinal vascular disease.

Easing the Burden of AMD Treatment

How to minimize the burden of anti-VEGF injections—for both patients and practices—without harming the patient.

Departments

Review News

Overprescription of Pinkeye Antibiotics Poses a Challenge

Ophthalmic Product Development Insights

Establishing the Target Product Profile

Editor's Page

The Voice of The Doctor

Medicare Q & A

Billing for Patients Enrolled in QMB

This month, we take a look at QMB and how its billing procedures might affect your practice.

Retinal Insider

How to Interpret Clinical Trial Outcomes

Making sense of primary and secondary endpoint outcomes in macular degeneration and diabetic macular edema trials.

Glaucoma Management

Premium Lenses, Cataract Surgery and Glaucoma

As technology improves and patient expectations rise, doctors treating glaucoma should consider offering premium options.

Therapeutic Topics

Balancing Biomarker Applications

Each of these indirect measures of therapeutic efficacy comes with its own strengths and weaknesses.

Product News

FDA Approval for Zerviate 0.24%

Research Review

Cross-linking in Pediatric Keratoconus

Wills Eye Resident Case Series

August 2017 Wills Eye Resident Case Series

Sudden blurred vision, floaters and metamorphopsia bring a 50-year-old woman to Wills Eye Hospital.

Current Issue